Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Exec Chat: Dexcom’s CEO Bullish On Year Ahead With G7 CGM Launch, Dexcom One CGM Expansion

Jan 21 2022

• By Marion Webb

Dexcom G7 — • Source: Alamy

Related Content

CES 2022: Abbott CEO Robert Ford Announces New Biowearables Line For Consumers, Paving The Way From Measuring Glucose To Ketone, Lactate, Alcohol

Jan 07 2022

Market Intel: Glucose Monitor Market Set To Explode As Patients Access Better Devices

May 25 2021

ADA 2021: Encouraging Trial Data On CGMs, Insulin Pens, Digital Solutions, And More

Jul 01 2021

Dexcom, Abbott File Dueling Lawsuits On Diabetes Management Technology

Jul 07 2021

Exec Chat: Dexcom Continues To Evolve Blood Glucose Measurement Market

Jul 07 2021

Dexcom Outlines Three-Pronged Growth Strategy To Reach $4-4.5BN Revenue Goal By 2025

Dec 11 2020

ACC 2020: Medtronic’s Resolute Onyx DES Meets Goals In US/Japan High Bleeding Risk Patients

Apr 09 2020

Dexcom’s Q2 Earnings Exceed Wall Street Expectations; Holds G7 Launch

Jul 30 2020

Related Companies

DexCom, Inc.

Tandem Diabetes Care, Inc.

Insulet Corporation

Abbott

Apple Inc.

Additional Topics

Business Strategies Coronavirus COVID-19 Launches FDA Leadership Commercial Clinical Trials Research & Development Diabetic Care Medical Device

More from Strategy

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window